Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer

Author(s):
Lam, S.W.; Noort, V. van der; Straaten, T. van der; Honkoop, A.H.; Peters, G.J.; Guchelaar, H.J. (0000-0002-7085-1383);
Published
2018
Publication type
Article / Letter to editor
Genetic polymorphismsCDACES2CapecitabineEfficacyBreast cancer
Date issued
2018-02-28
Language
English
Is part of
Pharmacological Research (2018), Vol. 128, p. 122-129
hdl
1887/95570
doi
10.10161/j.phrs.2017.08.005